Experiment 624562

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEchinacea purpurea (ASTERACEAE)
CitationGRIMM,W: MULLER,HH:. (1999). A RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF FLUID EXTRACT OF ECHINACEA PURPUREA ON THE INCIDENCE AND SEVERITY OF COLDS AND RESPIRATORY INFECTIONS.. 106(2)
Amount utilized
Compound isolated
DiseaseA TOTAL OF 109 PATIENTS WITH A HISTORY OF MORE THAN 3 COLDS OR RESPIRATORY INFECTIONS IN THE PRECEDING YEAR WERE RANDOMLY ASSINGED TO RECEIVE 4 ML FLUID EXTACT OF ECHINACEA PURPUREA OR 4 ML PLACEBO-JUICE TWICE A DAY IN A DOUBLE-BLIND MANNER. THE INCIDENCE AND SEVERITY OF COLDS AND RESPIRATORY INFECTIONS WERE DETERMINED DURING 8 WEEKS OF FOLLOW-UP, BASED ON PATIENT REPORTED SYMPTOMS TOGETHER WITH FINDINGS ON PHYSICAL EXAM. THE SEVERITY OF EACH INFECTION WAS GRADED BY THE INVESTIGATORS. RELATIVE RISKS (RR) AND 95% CONFIDENCE INTERVALS (CI) WERE ESTIMATED. DURING THE 8 WEEKS TREATMENT PERIOD, 35 (65%) OF 54 PATIENTS IN THE ECHINACEA GROUP AND 40 (74%) OF 54 PATIENTS IN THE PLACEBO GROUP HAD AT LEAST ON COLD OR RESPIRATORY INFECTION [RR=0.88; 95% CI (0.60, 1.22)]. THE AVERAGE NUMBER OF COLDS AND RESPIRATORY INFECTIONS PER PATIENT WAS 0.78 IN THE ECHANACEA GROUP, AND 0.93 IN THE PLACEBO GROUP [DIFFERENCE=0.15; 95% CI (-0.12, 0.41), P=0.33]. MEDIAN DURATION OF COLD AND RESPIRATORY INFECTIONS WAS 4.5 DAYS IN THE ECHINACEA GROUP AND 6.5 DAYS IN THE PLACEBO GROUP (95% CI: -1, +3 DAYS; P=0.45). THERE WERE NO SIGNIFICANT DIFFERENCE BETWEEN TREATMENT GROUPS IN THE NUMBER OF INFECTIONS IN EACH CATEGORY OF SEVERITY. SIDE EFFECTS WERE OBSERVED IN 11 PATIENTS (20%) OF THE ECHINACEA GROUP AND IN SEVEN PATIENTS (13%) OF THE PLACEBO GROUP (P=0.44). TREATMENT WITH FLUID EXTRACT OF ECHINACEA PURPUREA DID NOT SIGNIFICANTLY DECREASE THE INCIDENCE, DURATION OF COLDS AND RESPIRATORY INFECTIONS AS COMPARED WITH PLACEBO.
Dose amount4.0 ML
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractFLUIDEXTRACT
GenderGIVEN TO BOTH SEXES